4//SEC Filing
Lewicki John A. 4
Accession 0001140361-18-014120
CIK 0001302573other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 6:42 PM ET
Size
5.4 KB
Accession
0001140361-18-014120
Insider Transaction Report
Form 4
Lewicki John A.
EVP & Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-16+125,000→ 125,000 totalExercise: $2.98Exp: 2028-03-15→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of March 16, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeother
Related Parties
1- filerCIK 0001553352
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 6:42 PM ET
- Size
- 5.4 KB